Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kudingxiang Tongqi Suppository for Postoperative Ileus After Abdominal Gastrointestinal Anastomosis
CTR20131188Phase 3Active
- Sponsor
- Bozhong Shengjing
- Start
- May 2014
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative ileus (POI) comparing Kudingxiang Tongqi Suppository with Placebo (2 arms). Primary endpoints: Time to first postoperative flatus and Time to first postoperative defecation. Started May 2014; status: active.
02
Drugs
kudingxiang tongqi
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on CTR20131188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131188.